Interim Results from the Phase 1B and Phase 2 TORREY Open-label Extension Study of Seralutinib in Pulmonary Arterial Hypertension (PAH)
Pneumologie | March 18, 2025 | Volume: 79 | Issue: No issue available | Pages: No page available
10.1055/s-0045-1804612